Table 1.
Information concerning patients, tumours, and their p53 staining patterns
| Tn | Sex/age | Location | Smoking habits (cigarettes/day) | Drinking habits (U/day) | Grade | p53 immunostaining |
| T1 | M/81 | T | NS | <2 | M | Negative |
| T2 | F/45 | OL | >20 | >4 | M-P | Negative |
| T3 | M/60 | OL | NS | ND | W-M | Negative |
| T4 | F/55 | FM | >20 | >4 | W-M | Negative |
| T5 | M/58 | OL | unk | unk | M-P | Negative |
| T6 | M/70 | FM | 10–20 | >4 | M | Negative |
| T7 | F/63 | T | >20 | >4 | W-M | Negative |
| T8 | F/79 | T | NS | ND | W | Negative |
| T9 | M/71 | T/FM | 10–20 | 2–4 | W-M | Negative |
| T10 | M/52 | OL | >20 | unk | W | Negative |
| T11 | M/59 | T | NS | <2 | W-M | Negative |
| T12 | F/79 | T | NS | <2 | W | Negative |
| T13 | F/80 | T | NS | ND | M | Negative |
| T14 | M/72 | T | unk | >4 | M | Negative |
| T15 | M/63 | FM | 10–20 | 2–4 | W | Negative |
| T16 | M/59 | OL | >20 | >4 | W | Negative |
| T17 | M/68 | T | <10 | >4 | W-M | Negative |
| T18 | M/69 | T | 10–20 | 2–4 | W-M | Negative |
| T19 | M/67 | T | 10–20 | 2–4 | M | Negative |
| T20 | M/48 | T | unk | unk | W-M | Negative |
| T21 | F/28 | T | 10–20 | 2–4 | W-M | Negative |
| T22 | M/62 | T | >20 | 2–4 | M | Negative |
| T23 | M/59 | FM | >20 | >4 | M | <25% |
| T24 | F/105 | FM | NS | unk | VerrCa | <25% |
| T25 | F/66 | OL | NS | ND | W-M | <25% |
| T26 | F/57 | T | 10–20 | <2 | W | <25% |
| T27 | F/63 | T | >20 | >4 | W | <25% |
| T28 | F/73 | OL | NS | ND | W-M | <25%* |
| T29 | F/82 | T | unk | unk | M | <25%* |
| T30 | M/75 | T | 10–20 | >4 | W-M | <25% |
| T31 | F/81 | OL | NS | <2 | W | <25%* |
| T32 | F/76 | OL | NS | <2 | VerrCa | <25%* |
| T33 | F/86 | T | NS | ND | W-M | <25% |
| T34 | F/99 | OL | NS | unk | VerrCa | <25% |
| T35 | M/77 | OL | unk | unk | W | 25–50% |
| T36 | M/76 | OL | 10–20 | <2 | W-M | 25–50% |
| T37 | F/81 | T | NS | ND | W-M | 25–50% |
| T38 | F/56 | OL | unk | unk | M | 25–50% |
| T39 | F/87 | FM | unk | unk | M-P | 25–50% |
| T40 | F/69 | T | NS | ND | W-M | 25–50% |
| T41 | F/49 | FM | >20 | >4 | W-M | 50–75% |
| T42 | M/70 | T | 10–20 | >4 | W-M | 50–75% |
| T43 | F/50 | OL | unk | unk | M-P | 50–75% |
| T44 | M/58 | FM | >20 | >4 | M | 75–100% |
| T45 | F/55 | T | >20 | >4 | W-M | 75–100% |
| T46 | M/45 | OL | unk | unk | P | 75–100% |
| T47 | F/75 | T | NS | ND | M | 75–100% |
| T48 | F/47 | OC | >20 | 2–4 | M | 75–100% |
| T49 | M/56 | T | 10–20 | 2–4 | W-M | 75–100% |
| T50 | M/48 | OL | >20 | >4 | M | 75–100% |
| T51 | F/84 | FM | 10–20 | 2–4 | M | 75–100% |
| T52 | M/39 | T | >20 | 2–4 | W | 75–100% |
| T53 | F/51 | FM | 10–20 | >4 | W-M | 75–100%* |
| T54 | M/55 | T | 10–20 | 2–4 | W-M | 75–100% |
| T55 | M/81 | T | 10–20 | >4 | W-M | 75–100% |
*Coexistent areas with no p53 staining in the tumour cells.
Location of tumour: T, tongue; FM, floor of mouth; OL, other location (within the oral cavity); OC, oral cavity (location not specified). Grade (grade of differentiation): W, well differentiated SCC; W-M, well to moderately differentiated SCC; M, moderately differentiated SCC; M-P, moderately to poorly differentiated SCC; P, poor differentiated SCC; VerrCa, verrucous carcinoma.
ND, non-drinker; NS, non-smoker; U, units of alcoholic beverage; unk, unknown.